Experience in the use of Brirosa and Rozacom in secondary glaucoma

Background. Glaucoma is one of the most acute medical and social problems that cause enormous economic damage to society. Secondary glaucoma result complications such eye diseases as inflammation choroid eye, retinal vascular thrombosis. The purpose was determine effect Briroza Rozacom on condition visual analyzer in patients with secondary glaucoma. Material methods. study involved 58 (58 eyes) a unilateral process. All were divided into three groups. Groups 1 2 consisted se-condary after anterior recurrent iridocyclitis — 32 (32 remission relapse, respectively. Group 3 included (neovascular) glaucoma, which resulted from central vein stenosis (CVS) its branches 26 (26 eyes). Results. In first second groups, administration intraocular pressure decrease by 21.6 % (p = 0.001) 21.0 ± 3.5 mm Hg. After course treatment groups 2, electrical phosphene excitation decreased significantly 22.4 < 0.05). critical frequency flicker-induced mode 1.5 increased 20.6 0.05) 47 0.05), indicates an increase functional activity analyzer. Conclusions. inclusion drugs twice day for months effective due normalization